Complication of Endovascular Treatment of Intracranial Stenosis

国际民航组织 医学 血管成形术 冲程(发动机) 狭窄 人口 血管内治疗 重症监护医学 疾病 随机对照试验 心脏病学 内科学 外科 动脉瘤 机械工程 生物化学 化学 环境卫生 工程类 基因
作者
Fucheng Tian,Mithun G. Sattur,Devi Prasad Patra,Matthew E. Welz,Chandan Krishna,Karl R. Abi-Aad,Joseph B. Farnsworth,Bernard R. Bendok
出处
期刊:Elsevier eBooks [Elsevier]
卷期号:: 323-328
标识
DOI:10.1016/b978-0-323-55448-0.00051-6
摘要

Ischemic stroke is the leading cause of disability and the fourth-leading cause of mortality in the United States. Intracranial atherosclerotic disease (ICAD) is one of the major causes of ischemic stroke in the general population. The pathophysiology is not yet fully understood and, therefore, the optimal treatment modality has yet to be defined. The results of the two most recent large-scale randomized trials (VISSIT and SAMMPRIS) favored maximal medical therapy as a first-line treatment. However, the failure rate of medical therapy is about 12% at 1 year and increases to as high as 22% at 2 years. Furthermore, first generation devices were used in SAMMPRIS with a high reported periprocedural stroke rate. All these factors have led to a renewed interest in endovascular approaches to ICAD, specifically with the development of newer techniques and devices. In addition, even though the current data support medical management for this disease, there is a subset of patients who seem to benefit from angioplasty and stenting. Proper selection criteria must be met, however. Because of the complexity of the pathophysiology, the ever-improving endovascular options, and the high failure rate of current treatment paradigms, further studies are required to advance our understanding of ICAD. Only then will we be able to select the optimal treatment for each subset of patients.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
大鸣王潮完成签到 ,获得积分10
刚刚
Die发布了新的文献求助10
1秒前
爱吃百香果完成签到,获得积分20
2秒前
2秒前
Hello应助俭朴尔竹采纳,获得10
4秒前
4秒前
ashes完成签到,获得积分10
5秒前
B站萧亚轩完成签到,获得积分10
6秒前
汉堡包应助Fearless采纳,获得10
7秒前
8秒前
白华苍松发布了新的文献求助10
9秒前
Bob发布了新的文献求助10
12秒前
14秒前
15秒前
16秒前
阿尔曼完成签到 ,获得积分10
19秒前
雪糕发布了新的文献求助80
20秒前
20秒前
柠小檬c发布了新的文献求助10
20秒前
可爱的函函应助aaswsdw采纳,获得10
20秒前
LUpy发布了新的文献求助10
21秒前
大个应助精明的芷蕾采纳,获得10
21秒前
ding应助风中迎海采纳,获得10
21秒前
22秒前
23秒前
毛豆应助坚定睫毛膏采纳,获得10
23秒前
25秒前
Wangyan发布了新的文献求助10
26秒前
天天快乐应助虚心忘幽采纳,获得10
28秒前
搜集达人应助感动归尘采纳,获得10
28秒前
sun发布了新的文献求助10
28秒前
Jasper应助崔文兴采纳,获得10
30秒前
完美世界应助柠小檬c采纳,获得10
31秒前
31秒前
32秒前
映菡完成签到,获得积分10
34秒前
Wangyan完成签到,获得积分10
34秒前
so000应助雪糕采纳,获得10
35秒前
prosperp应助雪糕采纳,获得10
35秒前
Lucas应助雪糕采纳,获得30
35秒前
高分求助中
Production Logging: Theoretical and Interpretive Elements 2500
Востребованный временем 2500
Aspects of Babylonian celestial divination : the lunar eclipse tablets of enuma anu enlil 1500
Agaricales of New Zealand 1: Pluteaceae - Entolomataceae 1040
Healthcare Finance: Modern Financial Analysis for Accelerating Biomedical Innovation 1000
Classics in Total Synthesis IV: New Targets, Strategies, Methods 1000
지식생태학: 생태학, 죽은 지식을 깨우다 600
热门求助领域 (近24小时)
化学 医学 材料科学 生物 工程类 有机化学 生物化学 纳米技术 内科学 物理 化学工程 计算机科学 复合材料 基因 遗传学 物理化学 催化作用 细胞生物学 免疫学 电极
热门帖子
关注 科研通微信公众号,转发送积分 3458734
求助须知:如何正确求助?哪些是违规求助? 3053505
关于积分的说明 9036831
捐赠科研通 2742695
什么是DOI,文献DOI怎么找? 1504509
科研通“疑难数据库(出版商)”最低求助积分说明 695319
邀请新用户注册赠送积分活动 694519